2004 Surveillance Slides
This is an archived document. The links
and content are no longer being updated.
Return to 2004 Surveillance Slides
Main Menu
Completion of TB Therapy
United States, 1993–2002
|
Slide 26. Completion of TB Therapy, United States,
1993–2002. The reporting areas began collecting information
on completion of therapy in 1993 through the individual TB case
report form. The calculations exclude patients with an initial
isolate resistant to rifampin and children with meningeal, bone
or joint, or miliary disease. Overall completion remained at approximately
90%; however, completion of therapy in 1 year or less increased
from 64% in 1993 to approximately 80% in 1998–2002, the latest
year with available data. The current DHHS Healthy People 2010
objective is completion of therapy in 1 year or less in 90% of patients.
CDC is working with state and local health departments to evaluate
reasons for apparently delayed completion of therapy, which may
vary by jurisdiction. |
Back to 2004 Surveillance Slides Main
Page |
Last Reviewed: 05/18/2008 Content Source: Division of Tuberculosis Elimination
National Center for HIV/AIDS, Viral Hepatitis, STD, and TB Prevention
Back to Top of Page
You will need Adobe Acrobat Reader
v5.0 or higher to read pages that are in PDF format. Download the Adobe Acrobat Reader.
If you have difficulty accessing any
material on the DTBE Web site because of a disability, please contact
us in writing or via telephone and we will work with you to make the information
available.
Division of Tuberculosis Elimination
Attn: Content Manager, DTBE Web site
Centers for Disease Control and Prevention
1600 Clifton Rd., NE Mailstop E-10
Atlanta, GA 30333
CDC-INFO at (1-800) 232-4636
TTY: 1 (888) 232-6348
E-mail: tbinfo@cdc.gov
|
Home |
Site Map
| Contact Us
Accessibility
| Privacy Policy Notice |
FOIA
| USA.gov
CDC Home |
Search |
Health Topics A-Z
Centers for Disease Control & Prevention
National Center for HIV/AIDS,
Viral Hepatitis, STD, and TB Prevention
Division of Tuberculosis Elimination Please send comments/suggestions/requests to:
CDCINFO@cdc.gov
|